Texas Roadhouse, Inc.
Texas Roadhouse, Inc. (TXRH) Financial Performance & Income Statement Overview
Review Texas Roadhouse, Inc. (TXRH) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Texas Roadhouse, Inc. (TXRH) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Texas Roadhouse, Inc. TXRH financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.45B | $1.44B | $1.27B | $1.34B |
| Cost of Revenue | $1.25B | $1.19B | $1.06B | $1.09B |
| Gross Profit | $197.79M | $251.78M | $209.79M | $250.17M |
| Gross Profit Ratio | $0.14 | $0.18 | $0.16 | $0.19 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $56.22M | $57.39M | $55.13M | $58.15M |
| Operating Expenses | $56.22M | $113.23M | $107.77M | $107.36M |
| Total Costs & Expenses | -$1.31B | $1.30B | $1.17B | $1.20B |
| Interest Income | $1.30M | $0.00 | $0.00 | $1.68M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $48.80M | $49.24M | $44.51M | $42.91M |
| EBITDA | $185.06M | $187.88M | $147.38M | $192.02M |
| EBITDA Ratio | $0.13 | $0.13 | $0.12 | $0.14 |
| Operating Income | $141.57M | $138.55M | $102.02M | $142.82M |
| Operating Income Ratio | $0.10 | $0.10 | $0.08 | $0.11 |
| Other Income/Expenses (Net) | -$5.31M | $2.19M | $2.15M | $1.97M |
| Income Before Tax | $136.26M | $140.74M | $104.17M | $144.78M |
| Income Before Tax Ratio | $0.09 | $0.10 | $0.08 | $0.11 |
| Income Tax Expense | $20.20M | $22.23M | $17.40M | $21.71M |
| Net Income | $113.66M | $115.83M | $84.41M | $120.14M |
| Net Income Ratio | $0.08 | $0.08 | $0.07 | $0.09 |
| EPS | $1.71 | $1.74 | $1.27 | $1.80 |
| Diluted EPS | $1.70 | $1.73 | $1.26 | $1.79 |
| Weighted Avg Shares Outstanding | $66.48M | $66.68M | $66.70M | $66.78M |
| Weighted Avg Shares Outstanding (Diluted) | $66.71M | $67.00M | $66.94M | $67.04M |
Over the past four quarters, Texas Roadhouse, Inc. demonstrated steady revenue growth, increasing from $1.34B in Q2 2024 to $1.45B in Q1 2025. Operating income reached $141.57M in Q1 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $185.06M, reflecting operational efficiency. Net income dropped to $113.66M, with EPS at $1.71. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan